title: Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question?
authors: Team 15, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon (CRCL), University of Lyon (UCBL), LabEx DEVweCAN, , Lyon, France.
authors: Barbara
authors: B
authors: Testoni
authors: Massimo
authors: M
authors: Levrero
authors: David
authors: D
authors: Durantel
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects*; D008297:Male; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D012254:Ribavirin / Q000494:pharmacology*; D059467:Transcriptome / Q000187:drug effects*; D019562:Viral Load / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a
keywords: CHRONIC VIRAL HEPATITIS; HEPATITIS C